MediPro Collective was founded by a team of Pharmacy technologists and healthcare entrepreneurs who saw a gap in the market: independent MedSpa and clinic owners were increasingly being asked to prescribe complex compounded therapies (GLP-1 agonists, peptides, testosterone optimization protocols) without the infrastructure, pricing access, or clinical education to do so safely and profitably.

The branded pharmaceutical market prices these therapies beyond what many patients can afford, while the compounding landscape has historically been fragmented, opaque, and inconsistently regulated. Providers were caught in the middle, trying to serve patients while navigating confusing pricing structures, questionable quality claims, and limited clinical support.

MediPro Collective was our solution to these problems. We act as a trusted intermediary between pharmaceutical-grade compounding facilities and independent providers, negotiating preferential pricing, enforcing quality standards, and building the clinical education infrastructure that providers need to run excellent programs.